Publications by authors named "Nick Knezevic"

Article Synopsis
  • The field of neurostimulation for chronic pain is advancing quickly, emphasizing the importance of not just technological improvements but also surgical planning and postoperative care for optimal patient outcomes.
  • Experts conducted a thorough literature review from multiple databases to provide evidence-based recommendations for preoperative assessment, surgical techniques, and postoperative management, using rigorous grading criteria for studies.
  • The NACC's guidance aims to enhance the overall efficiency and safety of neuromodulation procedures, addressing the entire patient journey from planning to recovery, and is intended for use in the global medical community.
View Article and Find Full Text PDF

Because ketamine and magnesium block NMDA receptor activation by distinct mechanisms of action, we hypothesized that in a model of inflammatory pain in rats the combination of ketamine and magnesium might be more effective than ketamine alone. Antinociceptive activity was assessed by the formalin test in male Wistar rats (200-250 g). Animals were injected with 100 μL of 2.

View Article and Find Full Text PDF

Objective: The EMPOWER™ study evaluated spinal cord stimulation (SCS) safety and efficacy and the associated changes in psychosocial and functional outcomes.

Methods: Upon informed consent and IRB approval, 620 eligible subjects were enrolled prior to SCS trial evaluation and were assessed at baseline, 3, 6 and 12 months post-implant. Patient-reported pain relief (PRP), numerical rating scale (NRS), satisfaction, quality of life (QOL), and pain disability index (PDI) were assessed at all follow-up visits while the pain catastrophizing scale (PCS), short form-36 (SF-36), short form-McGill pain questionnaire version 2 (SF-MPQ-2), and the state-trait anxiety inventory (STAI) were assessed at the 6- and 12-month follow-up visits.

View Article and Find Full Text PDF

Since Its first description of botulism toxicity in 1820s, specific formulations of botulinum neurotoxin (BoNT) have been introduced with different clinical benefits. However, there is increasing number of adverse events reported to Food and Drug Administration. This report presents the case of 62-year-old woman with Parkinson's disease who received BoNT injections to treat painful spasticity in her hands.

View Article and Find Full Text PDF